MediWound (MDWD) Short-Term Debt repayments (2019 - 2025)
MediWound (MDWD) recorded quarterly Short-Term Debt repayments of -$248000.0 in Q1 2025, down 2.48% quarter-over-quarter from -$242000.0 in Q4 2024, and down 1.64% on a YoY basis from -$252133.3 in Q1 2024.
MediWound (MDWD) Short-Term Debt repayments (2019 - 2025) Analysis & Trends
MediWound's Short-Term Debt repayments history runs 7 years deep, the most recent figure standing at -$248000.0 for Q1 2025.
- In Q1 2025, Short-Term Debt repayments fell 1.64% year-over-year to -$248000.0; the TTM figure through Mar 2025 stood at -$932000.0 (down 10.3% YoY), while the FY2024 annual figure was -$928000.0, down 19.28% from the prior year.
- Short-Term Debt repayments was -$248000.0 for Q1 2025 at MediWound, down from -$242000.0 in the prior quarter.
- In the past five years, Short-Term Debt repayments ranged from a high of -$157000.0 in Q2 2023 to a low of -$248000.0 in Q1 2025.
- Historically, Short-Term Debt repayments has averaged -$199250.0 across 5 years, with a median of -$180500.0 in 2021.
- The sharpest annual moves came in 2021 and 2022: Short-Term Debt repayments plunged 820.0% in 2021, then rose 5.56% in 2022.
- A 5-year view of Short-Term Debt repayments shows it stood at -$180000.0 in 2021, then gained by 5.56% to -$170000.0 in 2022, then dropped by 20.0% to -$204000.0 in 2023, then retreated by 18.63% to -$242000.0 in 2024, then dropped by 2.48% to -$248000.0 in 2025.
- The last three Short-Term Debt repayments figures came in at -$248000.0 (Q1 2025), -$242000.0 (Q4 2024), and -$228000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ST Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 102,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -482,347.21 |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -248,000.00 |
| Mar 31, 2025 | -248,000.00 |
| Dec 31, 2024 | -242,000.00 |
| Dec 31, 2024 | -242,000.00 |
| Sep 30, 2024 | -228,000.00 |
| Sep 30, 2024 | -228,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Mar 31, 2024 | -244,000.00 |
| Mar 31, 2024 | -244,000.00 |
| Dec 31, 2023 | -204,000.00 |
| Dec 31, 2023 | -204,000.00 |
| Sep 30, 2023 | -240,000.00 |
| Sep 30, 2023 | -240,000.00 |
| Jun 30, 2023 | -157,000.00 |
| Jun 30, 2023 | -157,000.00 |
| Mar 31, 2023 | -177,000.00 |
| Mar 31, 2023 | -177,000.00 |
| Dec 31, 2022 | -170,000.00 |
| Dec 31, 2022 | -170,000.00 |